Ghost Tree Capital, LLC - Q4 2018 holdings

$276 Million is the total value of Ghost Tree Capital, LLC's 40 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .

 Value Shares↓ Weighting
TCDA  TRICIDA INC$5,895,000
-22.8%
250,0000.0%2.14%
+31.7%
VRAY  VIEWRAY INC$4,553,000
-35.1%
750,0000.0%1.65%
+10.7%
KDMN  KADMON HLDGS INC$4,160,000
-37.7%
2,000,0000.0%1.51%
+6.3%
BCRX  BIOCRYST PHARMACEUTICALS$4,035,000
+5.8%
500,0000.0%1.46%
+80.5%
ZFGN  ZAFGEN INC$3,713,000
-57.7%
750,0000.0%1.35%
-27.7%
ARVN  ARVINAS INC$2,249,000
-23.8%
175,0000.0%0.82%
+30.1%
UROV  UROVANT SCIENCES LTD$1,977,000
-45.1%
300,0000.0%0.72%
-6.3%
CBIO  CATALYST BIOSCIENCES INC$1,578,000
-26.8%
200,0000.0%0.57%
+25.1%
GNCA  GENOCEA BIOSCIENCES INC$1,011,000
-63.2%
3,525,0000.0%0.37%
-37.2%
MOTS  MOTUS GI HLDGS INC$311,000
-39.0%
100,0000.0%0.11%
+4.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2020-04-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC30Q3 20237.3%
ASCENDIS PHARMA A/S - ADR28Q3 202311.8%
BIOCRYST PHARMACEUTICALS INC25Q2 20232.4%
AMICUS THERAPEUTICS INC23Q3 20235.6%
SAREPTA THERAPEUTICS INC22Q3 20239.1%
SPDR SER TR20Q3 202216.9%
IOVANCE BIOTHERAPEUTICS INC18Q2 20235.5%
ROCKET PHARMACEUTICALS INC18Q2 20236.1%
SAGE THERAPEUTICS INC18Q1 20214.8%
IMMUNOMEDICS INC17Q2 20208.7%

View Ghost Tree Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-16
13F-HR2021-11-15

View Ghost Tree Capital, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Ghost Tree Capital, LLC's holdings